Table 2

Demographic and clinical characteristics of healthy controls and patients with bipolar I disorder

CharacteristicHealthy controls (n = 57)Bipolar I disorder (n = 33)p value*
Age, yr, mean ± SD39.6 ± 9.643.3 ± 10.90.09
Female, %63.257.60.66
PSQI score, mean ± SD3.3 ± 1.96.0 ± 4.0< 0.001
MEQ score, mean ± SD56.8 ± 9.551.0 ± 11.80.017
GAF score, mean ± SD99.5 ± 1.783.0 ± 10.6< 0.001
Qualified for higher education, %65.572.00.36
Positive family history, %024.2
Current medication, %
 Lithium54.6
 Valproate9.1
 Lamotrigine18.2
 Olanzapine9.1
 Quetiapine18.2
 Other atypical antipsychotic12.1
 Antidepressant15.2
  • GAF = Global Assessment of Functioning; MEQ = Morningness–Eveningness Questionnaire; PSQI = Pittsburgh Sleep Quality Index; SD = standard deviation.

  • * 2-tailed t test, unless stated otherwise.

  • χ2 test.

  • Parental history of bipolar disorder or schizophrenia.